Stock Picks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My guess is these guys have moved on to different careers.
Unfortunately they never had a working product.
Yes, if you watch Level 2 you can see PAUL has bought millions of shares over the past month.
Yes, I would say $2 easy by Thanksgiving if we get that China News we’ve been waiting on!
Yes! Middle East here we come!
Yes, very undervalued as they establish Endo products in US/China and adding Japan & India next. We could literally see $100s of millions per quarter with Endo in 2020. This will attract a ton of investors.
Gotta like that! FDA approved indications. We will announce the specific indications for which we are pursuing FDA approvals!
Total revenues for the quarter increased 2.5% year-over-year!
Since our last quarterly update, we successfully launched three new DNA-based test panels, including the full market launch of ARTguide™ following the successful Key Opinion Leader (KOL) beta launch, the KOL launch of FertilityDX™ and expanded distribution of PGxPLUS+™. ARTguide™, which helps detect genomic concerns associated with endometriosis and other infertility issues in women, has now been fully commercially launched and we expect material revenues to be generated beginning in calendar 2020!
“We are in the early stages of unlocking significant synergies among our business subsidiaries and are working to further advance our broad pipeline of data analytics, therapeutics and diagnostics to benefit both patients and our stakeholders."
4:22 PM
“We are in the early stages of unlocking significant synergies among our business subsidiaries and are working to further advance our broad pipeline of data analytics, therapeutics and diagnostics to benefit both patients and our stakeholders. We are fortunate to have highly experienced members of our advisory teams, management teams and board of directors to bring these products to market and truly improve the quality of life of individuals.”
They let their financials do the talking. Speaking of which they are due in a few days.
Will we are a 13 consecutive quarter of growth?
Hmmmm. Very interesting that the float is going to be getting smaller!
I wonder what the shorts will short against. :)
Great! If your really out, we shouldn’t hear from you again.
We shouldn’t see any more comments from you complaining. If we see more comments and complaints then we know you were bluffing.
Yes, no worries from me. Per IR, PRED is aware of the situation and working with OTCmarkets to get it fixed.
They literally uplisted them to QX exchange 12 days ago, so my guess is paperwork or clerical stuff.
Should be fixed momentarily. No worries. :)
Once uplisted to Nasdaq in a few weeks, it will be the 3rd exchange as well.
Great $PRED News this morning! LifeSci is big time. $PRED keeps amazing me.
https://www.marketwatch.com/press-release/predictive-technologies-group-engages-lifesci-partners-as-communications-partner-2019-10-31?siteid=nbsh
Looks like someone needs to cover 400k and my educated guess would be that they will cover that by the end of the week.
No one in their right mind would be short on PRED in November with financials coming out and insider buying allowed 2 days after financials are released.
Fact Checker: Float is 35 million.
https://www.otcmarkets.com/stock/PRED/security
You’re 0 for 2 today.
Can’t make this stuff up!
This guy just said “stem cell treatment of Endometriosis” LOL.
Ya, Major Gainz. You had nice timing on this one.
Nice to see the money flowing in. They were eating those walls. Shorts were blindsided this week by the surprise QX jump and volume.
Endo has launched and the sales force is unleashing in US & China. I would expect massive revenues to start pouring in.
Your end of year price target is very possible.
Awesome video just released!
https://www.predictivebiotech.com/video/#predictivebiotechoverview
"We are pleased to be accepted to trade on the OTCQX Best Market. Our previously announced listing application for the NASDAQ Market exchange is currently in the review process," Mr. Robinson concluded.
https://www.marketwatch.com/press-release/predictive-technologies-group-pred-upgrades-to-otcqxr-best-market-2019-10-24-7184230?siteid=nbsh
Lots of news eyes on PRED now on the higher exchange. Nasdaq requested QX uplist first. Right on track for Nasdaq uplist baby!
Naked Shorts are going to be looked at more than they were on the pinks. This is certainly a surprise to them. Huge step in the right direction this morning!
Ya baby! Great news! Huge step in the right direction for PRED!
“...pay close attention to the next 10K filings about their newer products sales trajectories.”
Thanks for the write up Mack Attack! Very informative
I like that timing too!
Elks back! Our good lucky charm. Looks like we are going higher this week.
I assume these are videos that are getting sent out to social media and will be sent to all the stem cell clinics to ramp up sales.
They look pretty damn professional and that ‘FDA Registered Lab’ looks super clean & top knotch.
My guess is the sales force will be expanding as this looks like the beginning of a huge marketing push!
Thanks again.
Awesome Video!
Notice how they use trigger words like “FDA Registered Lab” & “FDA Standards” & “FDA Good Manufacturing Standards”
I think they want you to know that FDA has been there and are approving what they are doing. Thanks for sharing.
A higher exchange followed quickly by Nasdaq is very good for “us real investors.”
Try harder Piper.
It’s pretty evident NASDAQ wants us to go to QX before they uplist us.
It makes it easier for them.
Nasdaq requested a new auditor and uplist to QX. So PRED will do what they say. Very exciting times for anyone accumulating shares!
You know damn well it will be past the $10-$20 range.
They literally just launched multiple products in China and going into hundreds of clinics right away. Combined with US sales, we are talking at least $1 Billion in sales in 2021, which would probably mean at least $500 million in profits to the company. That take us to the $25+ range on endo products alone.
Now add in Japan & India. $$$
Now add in other products and start doing the calculations. $$$
Me too CT! This is the week to load up.
Japan & India next. It’s not too hard to calculate where this is headed.
Massive revenues start now.
It’s probably market makers getting rid of their positions or adding to positions at .0001 in case the shell ticker is sold off eventually.
I can usually see all the trades on iHub by hitting the trades tab. I haven’t had a problem seeing the trades.
I honestly don’t know. I would say go visit them in person. I doubt you will find anyone at the offices anymore. I don’t even know if they have a office anymore.
They only thing left to do is go to their homes and ask if they are still in business. These guys disappeared and my bet they have moved on to new careers.
Wow! So 200 fertility clinics right away and partnered with one of China’s largest investment banks. This is going to start snowballing pretty fast.
There’s still people on this board that believe this company is still in business. LOL
Unbelievable news this morning...PRED just keeps executing.
I don't think people understand the magnitude of launching these products this week in front of 9000 doctors this week.
Yes, China has a high concentration of Endometriosis. Something in the genetics.
https://www.endonews.com/the-comparison-of-chinese-women-in-terms-of-risk-factors-genetics-and-treatment-of-endometriosis
$3.3 Billion in revenue just in United States sounds amazing. Thanks Thomas.
I’m hoping someone works up revenue estimates for China. I’m told that could be much 2x-4x higher!
Then maybe we figure up worldwide revenue...
It’s not too hard to see where this is headed over the next few years.
Wow! That is a very good sign. BIG PR today was released by Antenna Group.
(It looks like PRED has same PR firm as Berkshire Hathaway, 3M, Merck, & Pfizer now.)
https://www.antennagroup.com/results/clients